Sumatriptan (as succinate) 4mg/0.5mL, 6mg/0.5mL; for SC inj. Imitrex Injection is supplied as a clear, colorless to pale yellow, sterile, nonpyrogenic solution as either prefilled syringe and/or ...

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) announced yesterday that it has launched Sumatriptan Injection USP, Autoinjector System 6 mg/0.5 mL For Subcutaneous Use, a ...

Dr. Reddy’s Laboratories announced the launch of Sumatriptan Injection Autoinjector System for Subcutaneous Use, the generic version of GlaxoSmithKline‘s Imitrex STATdose Pen. Sumatriptan is a ...

The injection is an auto-injector system for subcutaneous use. It is a therapeutic equivalent generic version of Imitrex Statdose Pen (sumatriptan succinate) and was launched in the US market today ...

Dr Reddy’s Laboratories announced on today that it has launched Sumatriptan Injection USP, Autoinjector System 6 mg/0.5 mL, for subcutaneous use in the US market on February 25. It is a therapeutic ...

Sumatriptan oral tablet is a prescription drug that’s available as the brand-name drug Imitrex. It’s also available as a generic drug. Generic drugs usually cost less. In some cases, they may not be ...

“With the approval and launch of sumatriptan injection, we remain optimistic on progress of our other combination product development programs with Teva, which are currently under FDA review.” ...

BRIDGEWATER, N.J. Dr. Reddy’s announced Monday that it has launched an authorized generic version of GlaxoSmithKline’s Imitrex (sumatriptan succinate) tablets in 25mg, 50mg, and 100mg strengths. The ...

RESEARCH TRIANGLE PARK, N.C., Feb. 2 (UPI) -- GlaxoSmithKline said Thursday the Food and Drug Administration approved a new formulation of its migraine treatment Imitrex injection. The approval is for ...

Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated February 25, 2014, titled "Dr Reddy's annouces the Lanch of Sumatriptan Injection USP, Autoinjector System" Dr Reddys ...